{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:47:27Z","timestamp":1793126847422,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-025-08762-5","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T10:17:47Z","timestamp":1739528267000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effectiveness of human albumin for clinical outcome in aneurysmal subarachnoid hemorrhages: a protocol for randomized controlled (HASH) trial"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4620-9355","authenticated-orcid":false,"given":"Arshad","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsin","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nissar","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr El","family":"Mohamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazyona","family":"Al-Maadhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noman","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Al-Najjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Salam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghaya","family":"Al-Rumaihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ayyad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirajeddin","family":"Belkhair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghanem","family":"Al-Sulaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"8762_CR1","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1161\/STROKEAHA.123.042530","volume":"54","author":"Y Yang","year":"2023","unstructured":"Yang Y, Wang B, Ge X, Lu W, Peng C, Zhao Y, et al. Natural course of ruptured but untreated intracranial aneurysms: a multicenter 2-year follow-up study. Stroke. 2023;54:2087\u201395. https:\/\/doi.org\/10.1161\/STROKEAHA.123.042530.","journal-title":"Stroke"},{"key":"8762_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1056\/NEJMra052732","volume":"354","author":"JI Suarez","year":"2006","unstructured":"Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. New Engl J Med. 2006;354:387\u201396. https:\/\/doi.org\/10.1056\/NEJMra052732.","journal-title":"New Engl J Med"},{"key":"8762_CR3","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1136\/jnnp.2007.117655","volume":"78","author":"NK de Rooij","year":"2007","unstructured":"de Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry. 2007;78:1365\u201372. https:\/\/doi.org\/10.1136\/jnnp.2007.117655.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8762_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3233\/NRE-2012-0737","volume":"30","author":"PECA Passier","year":"2012","unstructured":"Passier PECA, Visser-Meily JMA, Van Zandvoort MJE, Rinkel GJE, Lindeman E, Post MWM. Predictors of long-term health-related quality of life in patients with aneurysmal subarachnoid hemorrhage. NeuroRehabilitation. 2012;30:137\u201345. https:\/\/doi.org\/10.3233\/NRE-2012-0737.","journal-title":"NeuroRehabilitation"},{"key":"8762_CR5","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1161\/01.STR.28.3.660","volume":"28","author":"JW Hop","year":"1997","unstructured":"Hop JW, Rinkel GJ, Algra A, Van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke. 1997;28:660\u20134. https:\/\/doi.org\/10.1161\/01.STR.28.3.660.","journal-title":"Stroke"},{"key":"8762_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3171\/jns.1990.73.1.0018","volume":"73","author":"NF Kassell","year":"1990","unstructured":"Kassell NF, Torner JC, Haley EC, Jane JA, Adams HP, Kongable GL. The international cooperative studyon the timing of aneurysm surgery: part 1: overall management results. J Neurosurg. 1990;73:18\u201336. https:\/\/doi.org\/10.3171\/jns.1990.73.1.0018.","journal-title":"J Neurosurg"},{"key":"8762_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/14651858.CD000277.pub3","volume":"2007","author":"SD Mees","year":"2007","unstructured":"Mees SD, Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007;2007:3. https:\/\/doi.org\/10.1002\/14651858.CD000277.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"8762_CR8","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S1474-4422(10)70087-9","volume":"9","author":"AA Rabinstein","year":"2010","unstructured":"Rabinstein AA, Lanzino G, Wijdicks EF. Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage. Lancet Neurol. 2010;9:504\u201319. https:\/\/doi.org\/10.1016\/S1474-4422(10)70087-9.","journal-title":"The Lancet Neurology"},{"key":"8762_CR9","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1227\/00006123-198409000-00010","volume":"15","author":"RA Solomon","year":"1984","unstructured":"Solomon RA, Post KD, McMurtry JG III. Depression of circulating blood volume in patients after subarachnoid hemorrhage: implications for the management of symptomatic vasospasm. Neurosurgery. 1984;15:354\u201361. https:\/\/doi.org\/10.1227\/00006123-198409000-00010.","journal-title":"Neurosurgery"},{"key":"8762_CR10","doi-asserted-by":"publisher","unstructured":"Jakobsen, M., Skj\u00f8dt, T., & Enevoldsen, E. Cerebral blood flow and metabolism following subarachnoid haemorrhage: effect of subarachnoid blood.\u00a0Acta neurologica scandinavica. 1991;83:226\u201333. https:\/\/doi-org.wcmq.idm.oclc.org\/https:\/\/doi.org\/10.1111\/j.1600-0404.1991.tb04687.x","DOI":"10.1111\/j.1600-0404.1991.tb04687.x"},{"key":"8762_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1161\/01.STR.31.2.383","volume":"31","author":"L Lennihan","year":"2000","unstructured":"Lennihan L, Mayer SA, Fink ME, Beckford A, Paik MC, Zhang H, et al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke. 2000;31:383\u201391. https:\/\/doi.org\/10.1161\/01.STR.31.2.383.","journal-title":"Stroke"},{"key":"8762_CR12","doi-asserted-by":"publisher","unstructured":"Rinkel, G. J., Feigin, V. L., Algra, A., & van Gijn, J. Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage.\u00a0Cochrane database of systematic reviews, 2004 (4) https:\/\/doi.org\/10.1002\/14651858.CD000483.pub2","DOI":"10.1002\/14651858.CD000483.pub2"},{"key":"8762_CR13","doi-asserted-by":"publisher","unstructured":"Mayer, S. A., Solomon, R. A., Fink, M. E., Lennihan, L., Stern, L., Beckford, A., ... & Klebanoff, L. M. Effect of 5% albumin solution on sodium balance and blood volume after subarachnoid hemorrhage.\u00a0Neurosurgery. 1998;42:759\u201366. https:\/\/doi.org\/10.1097\/00006123-199804000-00048","DOI":"10.1097\/00006123-199804000-00048"},{"key":"8762_CR14","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3171\/jns.2004.100.4.0585","volume":"100","author":"JI Suarez","year":"2004","unstructured":"Suarez JI, Shannon L, Zaidat OO, Suri MF, Singh G, Lynch G, et al. Effect of human albumin administration on clinical outcome and hospital cost in patients with subarachnoid hemorrhage. J Neurosurg. 2004;100:585\u201390. https:\/\/doi.org\/10.3171\/jns.2004.100.4.0585.","journal-title":"J Neurosurg"},{"key":"8762_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0006-8993(98)00674-X","volume":"804","author":"PW Huh","year":"1998","unstructured":"Huh PW, Belayev L, Zhao W, Busto R, Saul I, Ginsberg MD. The effect of high-dose albumin therapy on local cerebral perfusion after transient focal cerebral ischemia in rats. Brain Res. 1998;804:105\u201313. https:\/\/doi.org\/10.1016\/S0006-8993(98)00674-X.","journal-title":"Brain Res"},{"key":"8762_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1089\/neu.1999.16.445","volume":"16","author":"L Belayev","year":"1999","unstructured":"Belayev L, Alonso OF, Huh PW, Zhao W, Busto R, Ginsberg MD. Posttreatment with high-dose albumin reduces histopathological damage and improves neurological deficit following fluid percussion brain injury in rats. J Neurotrauma. 1999;16:445\u201353. https:\/\/doi.org\/10.1089\/neu.1999.16.445.","journal-title":"J Neurotrauma"},{"key":"8762_CR17","doi-asserted-by":"publisher","unstructured":"Matsui, T., & Asano, T. The hemodynamic effects of prolonged albumin administration in beagle dogs exposed to experimental subarachnoid hemorrhage.\u00a0Neurosurgery. 1993;32:79\u201384. https:\/\/doi.org\/10.1227\/00006123-199301000-00012","DOI":"10.1227\/00006123-199301000-00012"},{"key":"8762_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s12028-010-9392-8","volume":"13","author":"JI Suarez","year":"2010","unstructured":"Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rational design Neurocrit care. 2010;13:263\u201377. https:\/\/doi.org\/10.1007\/s12028-010-9392-8.","journal-title":"Rationale and design Neurocritical care"},{"key":"8762_CR19","doi-asserted-by":"publisher","unstructured":"Suarez, J. I., Martin, R. H., Calvillo, E., Bershad, E. M., & Venkatasubba Rao, C. P. Effect of human albumin on TCD vasospasm, DCI, and cerebral infarction in subarachnoid hemorrhage: the ALISAH study.\u00a0Neurovascular events after subarachnoid hemorrhage: towards experimental and clinical standardisation. 2015;287\u201390. https:\/\/doi.org\/10.1007\/978-3-319-04981-6_48","DOI":"10.1007\/978-3-319-04981-6_48"},{"key":"8762_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1161\/STROKEAHA.111.633958","volume":"43","author":"JI Suarez","year":"2012","unstructured":"Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, MacDonald RL, et al. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43:683\u201390. https:\/\/doi.org\/10.1161\/STROKEAHA.111.633958.","journal-title":"Stroke"},{"key":"8762_CR21","doi-asserted-by":"publisher","unstructured":"Ali A, Rajeswaran AB, Shaikh N, Al-Rumaihi G, Al-Sulaiti G. Role of albumin-induced volume expansion therapy for cerebral vasospasm in aneurysmal subarachnoid hemorrhage: a systematic review. J Neurosci Rural Pract. 2023;14:582\u201390. https:\/\/doi.org\/10.25259\/JNRP_372_2023","DOI":"10.25259\/JNRP_372_2023"},{"key":"8762_CR22","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1161\/hs0901.095677","volume":"32","author":"J Claassen","year":"2001","unstructured":"Claassen J, Bernardini GL, Kreiter K, Bates J, Du YE, Copeland D, et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke. 2001;32:2012\u201320. https:\/\/doi.org\/10.1161\/hs0901.095677.","journal-title":"Stroke"},{"key":"8762_CR23","unstructured":"Campos Munoz A, Jain NK, Gupta M. Albumin colloid. [Updated 2023 Apr 22]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.\u00a0Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK534241\/"},{"key":"8762_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13613-021-00960-z","volume":"11","author":"V Rass","year":"2021","unstructured":"Rass V, Bogossian EG, Ianosi BA, Peluso L, Kofler M, Lindner A, et al. The effect of the volemic and cardiac status on brain oxygenation in patients with subarachnoid hemorrhage: a bi-center cohort study. Ann Intensive Care. 2021;11:1\u20132. https:\/\/doi.org\/10.1186\/s13613-021-00960-z.","journal-title":"Ann Intensive Care"},{"key":"8762_CR25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s001340050043","volume":"26","author":"SG Sakka","year":"2000","unstructured":"Sakka SG, R\u00fchl CC, Pfeiffer UJ, Beale R, McLuckie A, Reinhart K, et al. Assessment of cardiac preload and extravascular lung water by single transpulmonary thermodilution. Intensive Care Med. 2000;26:180\u20137. https:\/\/doi.org\/10.1007\/s001340050043.","journal-title":"Intensive Care Med"},{"key":"8762_CR26","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1161\/STROKEAHA.113.001015","volume":"44","author":"H Yoneda","year":"2013","unstructured":"Yoneda H, Nakamura T, Shirao S, Tanaka N, Ishihara H, Suehiro E, et al. Multicenter prospective cohort study on volume management after subarachnoid hemorrhage: hemodynamic changes according to severity of subarachnoid hemorrhage and cerebral vasospasm. Stroke. 2013;44:2155\u20136. https:\/\/doi.org\/10.1161\/STROKEAHA.113.001015.","journal-title":"Stroke"},{"key":"8762_CR27","unstructured":"Loomis AL, Chakko MN. Doppler trans-cranial assessment, protocols, and interpretation. [Updated 2023 Aug 21]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.\u00a0Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK570636\/"},{"key":"8762_CR28","doi-asserted-by":"publisher","unstructured":"Park SH, Kim TJ, Ko SB. Transcranial Doppler monitoring in subarachnoid hemorrhage. J Neurosonol Neuroimaging. 2022;30;14:1\u20139. https:\/\/doi.org\/10.31728\/jnn.2022.00115","DOI":"10.31728\/jnn.2022.00115"},{"key":"8762_CR29","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1055\/s-0042-1750838","volume":"17","author":"MM Khan","year":"2022","unstructured":"Khan MM, Shaikh N, Yousaf Z, Sultan H, Sadek G, Khan A, et al. Risk factors for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage: a tertiary care center experience. Asian J Neurosurg. 2022;17:242\u20137. https:\/\/doi.org\/10.1055\/s-0042-1750838.","journal-title":"Asian Journal of Neurosurgery"},{"key":"8762_CR30","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","volume":"41","author":"MD Vergouwen","year":"2010","unstructured":"Vergouwen MD, Vermeulen M, van Gijn J, Rinkel GJ, Wijdicks EF, Muizelaar JP, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41:2391\u20135. https:\/\/doi.org\/10.1161\/STROKEAHA.110.589275.","journal-title":"Stroke"},{"key":"8762_CR31","doi-asserted-by":"publisher","unstructured":"Huttunen J, Kurki MI, von und zu Fraunberg M, Koivisto T, Ronkainen A, Rinne J, et al. Epilepsy after aneurysmal subarachnoid hemorrhage: a population-based, long-term follow-up study. Neurology. 2015;84:2229\u201337. https:\/\/doi.org\/10.1212\/WNL.0000000000001643","DOI":"10.1212\/WNL.0000000000001643"},{"key":"8762_CR32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s12028-017-0440-5","volume":"28","author":"T Human","year":"2018","unstructured":"Human T, Diringer MN, Allen M, Zipfel GJ, Chicoine M, Dacey R, et al. A randomized trial of brief versus extended seizure prophylaxis after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2018;28:169\u201374. https:\/\/doi.org\/10.1007\/s12028-017-0440-5.","journal-title":"Neurocrit Care"},{"key":"8762_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-057917","volume":"12","author":"Y Chen","year":"2022","unstructured":"Chen Y, Fang M, Wu P, Xie Z, Wu H, Wu Q, et al. Seizure prophylaxis following aneurysmal subarachnoid haemorrhage (SPSAH): study protocol for a multicentre randomised placebo-controlled trial of short-term sodium valproate prophylaxis in patients with acute subarachnoid haemorrhage. BMJ Open. 2022;12: e057917. https:\/\/doi.org\/10.1136\/bmjopen-2021-057917.","journal-title":"BMJ Open"},{"key":"8762_CR34","doi-asserted-by":"publisher","unstructured":"Ramos MB, Teixeira MJ, Figueiredo EG. Seizures and epilepsy following subarachnoid hemorrhage: a review on incidence, risk factors, outcome and treatment. Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery. 2018;37:206\u201312. https:\/\/www.thieme-connect.com\/products\/ejournals\/pdf\/https:\/\/doi.org\/10.1055\/s-0038-1672202.pdf","DOI":"10.1055\/s-0038-1672202.pdf"},{"key":"8762_CR35","doi-asserted-by":"publisher","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann int med. 2013;158:200\u201307. https:\/\/doi.org\/10.7326\/0003-4819-158-3-201302050-00583.","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"8762_CR36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s12028-023-01812-3","volume":"39","author":"A Abdulazim","year":"2023","unstructured":"Abdulazim A, Heilig M, Rinkel G, Etminan N. Diagnosis of delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage and triggers for intervention. Neurocrit Care. 2023;39:311\u20139. https:\/\/doi.org\/10.1007\/s12028-023-01812-3.","journal-title":"Neurocrit Care"},{"key":"8762_CR37","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1177\/23969873231209819","volume":"9","author":"B Tokareva","year":"2024","unstructured":"Tokareva B, Meyer L, Heitkamp C, Wentz R, Faizy TD, Meyer HS, et al. Early and recurrent cerebral vasospasms after aneurysmal subarachnoid hemorrhage: the impact of age. Eur Stroke J. 2024;9:172\u20139. https:\/\/doi.org\/10.1177\/23969873231209819.","journal-title":"Eur Stroke J"},{"key":"8762_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41983-018-0050-y","volume":"55","author":"HG Nassar","year":"2019","unstructured":"Nassar HG, Ghali AA, Bahnasy WS, Elawady MM. Vasospasm following aneurysmal subarachnoid hemorrhage: prediction, detection, and intervention. Egyptian J neurol, psychiatry neurosurg. 2019;55:1\u20136. https:\/\/doi.org\/10.1186\/s41983-018-0050-y.","journal-title":"The Egyptian journal of neurology, psychiatry and neurosurgery"},{"key":"8762_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/15910199080140S105","volume":"14","author":"S Bracard","year":"2008","unstructured":"Bracard S, Schmitt E. Vasospasm and delayed consequences. Intervent neuroradiol. 2008;14:17\u201322. https:\/\/doi.org\/10.1177\/15910199080140S105.","journal-title":"Intervent neuroradiol"},{"key":"8762_CR40","doi-asserted-by":"publisher","unstructured":"Park SH, Kim TJ, Ko SB. Transcranial Doppler monitoring in subarachnoid hemorrhage. J Neurosonol Neuroimaging. 2022. 30;14:1\u20139. https:\/\/doi.org\/10.31728\/jnn.2022.00115","DOI":"10.31728\/jnn.2022.00115"},{"key":"8762_CR41","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1164\/ajrccm.162.4.9910106","volume":"162","author":"AM Cantin","year":"2000","unstructured":"Cantin AM, Paquette B, Richter M, Larivee P. Albumin-mediated regulation of cellular glutathione and nuclear factor kappa B activation. Am J Respir Crit Care Med. 2000;162:1539\u201346. https:\/\/doi.org\/10.1164\/ajrccm.162.4.9910106.","journal-title":"Am J Respir Crit Care Med"},{"key":"8762_CR42","doi-asserted-by":"publisher","first-page":"H398","DOI":"10.1152\/ajpheart.00558.2001","volume":"283","author":"K Osterloh","year":"2002","unstructured":"Osterloh K, Ewert U, Pries AR. Interaction of albumin with the endothelial cell surface. American Journal of Physiology-Heart and Circulatory Physiology. 2002;283:H398\u2013405. https:\/\/doi.org\/10.1152\/ajpheart.00558.2001.","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"key":"8762_CR43","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S0008-6363(02)00492-3","volume":"55","author":"WJ Zhang","year":"2002","unstructured":"Zhang WJ, Frei B. Albumin selectively inhibits TNF\u03b1-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells. Cardiovasc Res. 2002;55:820\u20139. https:\/\/doi.org\/10.1016\/S0008-6363(02)00492-3.","journal-title":"Cardiovasc Res"},{"key":"8762_CR44","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1242\/jcs.109.10.2571","volume":"109","author":"H Zoellner","year":"1996","unstructured":"Zoellner H, H\u00f6fler M, Beckmann R, Hufnagl P, Vanyek E, Bielek E, Wojta J, Fabry A, Lockie S, Binder BR. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J Cell Sci. 1996;109:2571\u201380. https:\/\/doi.org\/10.1242\/jcs.109.10.2571.","journal-title":"J Cell Sci"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-08762-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-08762-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-08762-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T21:45:45Z","timestamp":1739569545000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-08762-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8762"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-08762-5","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"29 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee approval received from the local IRB. Informed consent duly signed and dated from each participant is obligatory as IRB regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Consent for publication is not applicable as no patient data is being disclosed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices, being used in this trial.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"53"}}